发明授权
- 专利标题: Piperidine derivatives useful as CCR5 antagonists
- 专利标题(中): 哌啶衍生物可用作CCR5拮抗剂
-
申请号: US10628933申请日: 2003-07-29
-
公开(公告)号: US07384948B2公开(公告)日: 2008-06-10
- 发明人: Anandan Palani , Michael W. Miller , Jack D. Scott
- 申请人: Anandan Palani , Michael W. Miller , Jack D. Scott
- 申请人地址: US NJ Kenilworth
- 专利权人: Schering Corporation
- 当前专利权人: Schering Corporation
- 当前专利权人地址: US NJ Kenilworth
- 代理商 Krishna G. Banerjee
- 主分类号: A61K31/505
- IPC分类号: A61K31/505 ; C07D401/14
摘要:
The present invention provides a compound of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, R9, R10, A and B are as defined in the specification. The present invention also provides pharmaceutical compositions containing the compound of this invention, and methods of treatment using the compound of this invention. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
公开/授权文献
- US20040092745A1 Piperidine derivatives useful as CCR5 antagonists 公开/授权日:2004-05-13
信息查询